Spike protein (inc vax) induced immunodeficiency & carcinogenesis megathread #2: SARSāCoVā2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
doorlesscarp953.substack.com
Any extracts used in the following article are for non commercial research and educational purposes only and may be subject to copyright from their respective owners.
SARSāCoVā2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro (2021)
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) has led to the coronavirus disease 2019 (COVIDā19) pandemic, severely affecting public health and the global economy. Adaptive immunity plays a crucial role in fighting against SARSāCoVā2 infection and directly influences the clinical outcomes of patients. Clinical studies have indicated that patients with severe COVIDā19 exhibit delayed and weak adaptive immune responses; however, the mechanism by which SARSāCoVā2 impedes adaptive immunity remains unclear. Here, by using an in vitro cell line, we report that the SARSāCoVā2 spike protein significantly inhibits DNA damage repair, which is required for effective V(D)J recombination in adaptive immunity. Mechanistically, we found that the spike protein localizes in the nucleus and inhibits DNA damage repair by impeding key DNA repair protein BRCA1 and 53BP1 recruitment to the damage site. Our findings reveal a potential molecular mechanism by which the spike protein might impede adaptive immunity and underscore the potential side effects of full-length spike-based vaccines.
Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) is responsible for the ongoing coronavirus disease 2019 (COVIDā19) pandemic that has resulted in more than 2.3 million deaths. SARSāCoVā2 is an enveloped single positiveāsense RNA virus that consists of structural and nonāstructural proteins [1]. After infection, these viral proteins hijack and dysregulate the host cellular machinery to replicate, assemble, and spread progeny viruses [2]. Recent clinical studies have shown that SARSāCoVā2 infection extraordinarily affects lymphocyte number and function [3,4,5,6]. Compared with mild and moderate survivors, patients with severe COVIDā19 manifest a significantly lower number of total T cells, helper T cells, and suppressor T cells [3,4]. Additionally, COVIDā19 delays IgG and IgM levels after symptom onset [5,6]. Collectively, these clinical observations suggest that SARSāCoVā2 affects the adaptive immune system. However, the mechanism by which SARSāCoVā2 suppresses adaptive immunity remains unclear.
As two critical host surveillance systems, the immune and DNA repair systems are the primary systems that higher organisms rely on for defense against diverse threats and tissue homeostasis. Emerging evidence indicates that these two systems are interdependent, especially during lymphocyte development and maturation [7]. As one of the major double-strand DNA break (DSB) repair pathways, non-homologous end joining (NHEJ) repair plays a critical role in lymphocyteāspecific recombinationāactivating gene endonuclease (RAG) āmediated V(D)J recombination, which results in a highly diverse repertoire of antibodies in B cell and T cell receptors (TCRs) in T cells [8]. For example, loss of function of key DNA repair proteins such as ATM, DNAāPKcs, 53BP1, et al., leads to defects in the NHEJ repair which inhibit the production of functional B and T cells, leading to immunodeficiency [7,9,10,11]. In contrast, viral infection usually induces DNA damage via different mechanisms, such as inducing reactive oxygen species (ROS) production and host cell replication stress [12,13,14]. If DNA damage cannot be properly repaired, it will contribute to the amplification of viral infection-induced pathology. Therefore, we aimed to investigate whether SARSāCoVā2 proteins hijack the DNA damage repair system, thereby affecting adaptive immunity in vitro.
[2. Materials and Methods]
3. Results
3.1. Effect of NuclearāLocalized SARSāCoVā2 Viral Proteins on DNA Damage Repair
DNA damage repair occurs mainly in the nucleus to ensure genome stability. Although SARSāCoVā2 proteins are synthesized in the cytosol [1], some viral proteins are also detectable in the nucleus, including Nsp1, Nsp5, Nsp9, Nsp13, Nsp14, and Nsp16 [19]. We investigated whether these nuclear-localized SARSāCoVā2 proteins affect the host cell DNA damage repair system. For this, we constructed these viral protein expression plasmids together with spike and nucleoprotein expression plasmids, which are generally considered cytosolālocalized proteins. We confirmed their expression and localization by immunoblotting and immunofluorescence (Figure 1A andĀ Figure S1A). Our results were consistent with those from previous studies [19]; Nsp1, Nsp5, Nsp9, Nsp13, Nsp14, and Nsp16 proteins are indeed localized in the nucleus, and nucleoproteins are mainly localized in the cytosol. Surprisingly, we found the abundance of the spike protein in the nucleus (Figure 1A). NHEJ repair and homologous recombination (HR) repair are two major DNA repair pathways that not only continuously monitor and ensure genome integrity but are also vital for adaptive immune cell functions [9]. To evaluate whether these viral proteins impede the DSB repair pathway, we examined the repair of a site-specific DSB induced by the IāSceI endonuclease using the direct repeatāgreen fluorescence protein (DRāGFP) and the total-NHEJ-GFP (EJ5āGFP) reporter systems for HR and NHEJ, respectively [15,16]. Overexpression of Nsp1, Nsp5, Nsp13, Nsp14, and spike proteins diminished the efficiencies of both HR and NHEJ repair (Figure 1BāE andĀ Figure S2A,B). Moreover, we also found that Nsp1, Nsp5, Nsp13, and Nsp14 overexpression dramatically suppressed proliferation compared with other studied proteins (Figure S3A,B). Therefore, the inhibitory effect of Nsp1, Nsp5, Nsp13, and Nsp14 on DNA damage repair may be due to secondary effects, such as growth arrest and cell death. Interestingly, overexpressed spike protein did not affect cell morphology or proliferation but significantly suppressed both HR and NHEJ repair (Figure 1BāE,Ā Figures S2A,B and S3A,B).
Figure 1.Ā Effect of severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) nuclear-localized proteins on DNA damage repair. (A) Subcellular distribution of the SARSāCoVā2 proteins. Immunofluorescence was performed at 24 h after transfection of the plasmid expressing the viral proteins into HEK293T cells. Scale bar: 10 Āµm. (B) Schematic of the EJ5-GFP reporter used to monitor non-homologous end joining (NHEJ). (C) Effect of empty vector (E.V) and SARSāCoVā2 proteins on NHEJ DNA repair. The values represent the mean Ā± standard deviation (SD) from three independent experiments (see representative FACS plots inĀ Figure S2A). (D) Schematic of the DR-GFP reporter used to monitor homologous recombination (HR). (E) Effect of E.V and SARSāCoVā2 proteins on HR DNA repair. The values represent the mean Ā± SD from three independent experiments (see representative FACS plots inĀ Figure S2B). The values represent the mean Ā± SD,Ā nĀ = 3. Statistical significance was determined using one-way analysis of variance (ANOVA) in (C,E). **Ā pĀ < 0.01, ***Ā pĀ < 0.001, ****Ā pĀ < ā0.0001.
3.2. SARSāCoVā2 Spike Protein Inhibits DNA Damage Repair
Because spike proteins are critical for mediating viral entry into host cells and are the focus of most vaccine strategies [20,21], we further investigated the role of spike proteins in DNA damage repair and its associated V(D)J recombination. Spike proteins are usually thought to be synthesized on the rough endoplasmic reticulum (ER) [1]. After posttranslational modifications such as glycosylation, spike proteins traffic via the cellular membrane apparatus together with other viral proteins to form the mature virion [1]. Spike protein contains two major subunits, S1 and S2, as well as several functional domains or repeats [22] (Figure 2A). In the native state, spike proteins exist as inactive fullālength proteins. During viral infection, host cell proteases such as furin protease activate the S protein by cleaving it into S1 and S2 subunits, which is necessary for viral entry into the target cell [23]. We further explored different subunits of the spike protein to elucidate the functional features required for DNA repair inhibition. Only the fullālength spike protein strongly inhibited both NHEJ and HR repair (Figure 2BāE andĀ Figure S4A,B). Next, we sought to determine whether the spike protein directly contributes to genomic instability by inhibiting DSB repair. We monitored the levels of DSBs using comet assays. Following different DNA damage treatments, such as Ī³āirradiation, doxorubicin treatment, and H2O2Ā treatment, there is less repair in the presence of the spike protein (Figure 2F,G). Together, these data demonstrate that the spike protein directly affects DNA repair in the nucleus.
Figure 2.Ā Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) spike protein inhibits DNA damage repair. (A) Schematic of the primary structure of the SARSāCoVā2 spike protein. The S1 subunit includes an Nāterminal domain (NTD, 14ā305 residues) and a receptorābinding domain (RBD, 319ā541 residues). The S2 subunit consists of the fusion peptide (FP, 788ā806 residues), heptapeptide repeat sequence 1 (HR1, 912ā984 residues), HR2 (1163ā1213 residues), TM domain (TM, 1213ā1237 residues), and cytoplasm domain (CT,1237ā1273 residues). (B,C) Effect of titrated expression of the spike protein on DNA repair in HEKā293T cells. (D,E) Only full-length spike protein inhibits non-homologous end joining (NHEJ) and homologous recombination (HR) DNA repair. The values represent the mean Ā± SD from three independent experiments (see representative FACS plots inĀ Figure S4A,B). (F) Fullālength spike (SāFL) proteinātransfected HEK293T cells exhibited more DNA damage than empty vector-, S1ā, and S2ātransfected cells under different DNA damage conditions. For doxorubicin: 4 Āµg/mL, 2 h. For Ī³āirradiation: 10 Gy, 30 min. For H2O2: 100 ĀµM, 1 h. Scale bar: 50 Āµm. (G) Corresponding quantification of the comet tail moments from 20 different fields withĀ nĀ > 200 comets of three independent experiments. Statistical significance was assessed using a two-way analysis of variance (ANOVA). NS (Not Significant): *Ā pĀ > 0.05, **Ā pĀ <ā0.01, ***Ā pĀ < 0.001, ****Ā pĀ < 0.0001.
3.3. Spike Proteins Impede the Recruitment of DNA Damage Repair Checkpoint Proteins
To confirm the existence of spike protein in the nucleus, we performed subcellular fraction analysis and found that spike proteins are not only enriched in the cellular membrane fraction but are also abundant in the nuclear fraction, with detectable expression even in the chromatinābound fraction (Figure 3A). We also observed that the spike has three different forms, the higher band is a highly glycosylated spike, the middle one is a fullālength spike, and the lower one is a cleaved spike subunit. Consistent with the comet assay, we also found the upregulation of the DNA damage marker, Ī³āH2A.X, in spike proteināoverexpressed cells under DNA damage conditions (Figure 3B). A recent study suggested that spike proteins induce ER stress and ERāassociated protein degradation [24]. To exclude the possibility that the spike protein inhibits DNA repair by promoting DNA repair protein degradation, we checked the expression of some essential DNA repair proteins in NHEJ and HR repair pathways and found that these DNA repair proteins were stable after spike protein overexpression (Figure 3C). To determine how the spike protein inhibits both NHEJ and HR repair pathways, we analyzed the recruitment of BRCA1 and 53BP1, which are the key checkpoint proteins for HR and NHEJ repair, respectively. We found that the spike protein markedly inhibited both BRCA1 and 53BP1 foci formation (Figure 3DāG). Together, these data show that the SARSāCoVā2 fullālength spike protein inhibits DNA damage repair by hindering DNA repair protein recruitment.
Figure 3.Ā Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) spike protein impedes the recruitment of DNA damage repair checkpoint proteins. (A) Membrane fraction (MF), cytosolic fraction (CF), soluble nuclear fraction (SNF), and chromatin-bound fraction (CBF) from HEK293T cells transfected with SARSāCoVā2 spike protein were immunoblotted for His-tag spike and indicated proteins. (B) Left: Immunoblots of DNA damage marker Ī³H2AX in empty vector (E.V)ā and spike proteināexpressing HEK293T cells after 10 Gy Ī³-irradiation. Right: corresponding quantification of immunoblots in left. The values represent the mean Ā± SD (nĀ = 3). Statistical significance was determined using StudentāsĀ t-test. ****Ā pā< 0.0001. (C) Immunoblots of DNA damage repair related proteins in spike proteināexpressing HEK293T cells. (D) Representative images of 53BP1 foci formation in E.Vā and spike protein-expressing HEK293 cells exposed to 10 Gy Ī³āirradiation. Scale bar: 10 Āµm. (E) Quantitative analysis of 53BP1 foci per nucleus. The values represent the mean Ā± SEM,Ā nĀ = 50. (F) BRCA1 foci formation in empty vector- and spike protein-expressing HEK293 cells exposed to 10 Gy Ī³āirradiation. Scale bar: 10 Āµm. (G). Quantitative analysis of BRCA1 foci per nucleus. The values represent the mean Ā± SEM,Ā nĀ = 50. Statistical significance was determined using StudentāsĀ t-test. ****Ā pĀ < 0.0001.
3.4. Spike Protein Impairs V(D)J Recombination In vitro
DNA damage repair, especially NHEJ repair, is essential for V(D)J recombination, which lies at the core of B and T cell immunity [9]. To date, many approved SARSāCoVā2 vaccines, such as mRNA vaccines and adenovirusāCOVIDā19 vaccines, have been developed based on the fullālength spike protein [25]. Although it is debatable whether SARSāCoVā2 directly infects lymphocyte precursors [26,27], some reports have shown that infected cells secrete exosomes that can deliver SARSāCoVā2 RNA or protein to target cells [28,29]. We further tested whether the spike protein reduced NHEJāmediated V(D)J recombination. For this, we designed an in vitro V(D)J recombination reporter system according to a previous study [18] (Figure S5). Compared with the empty vector, spike protein overexpression inhibited RAGāmediated V(D)J recombination in this in vitro reporter system (Figure 4).
Figure 4.Ā Spike protein impairs V(D)J recombination in vitro. (A) Schematic of the V(D)J reporter system. (B) Representative plots of flow cytometry show that the SARSāCoVā2 spike protein impedes V(D)J recombination in vitro. (C) Quantitative analysis of relative V(D)J recombination. The values represent the mean Ā± SD,Ā nĀ = 3. Statistical significance was determined using StudentāsĀ t-test. ****Ā pĀ < 0.0001.
4. Discussion
Our findings provide evidence of the spike protein hijacking the DNA damage repair machinery and adaptive immune machinery in vitro. We propose a potential mechanism by which spike proteins may impair adaptive immunity by inhibiting DNA damage repair. Although no evidence has been published that SARSāCoVā2 can infect thymocytes or bone marrow lymphoid cells, our in vitro V(D)J reporter assay shows that the spike protein intensely impeded V(D)J recombination. Consistent with our results, clinical observations also show that the risk of severe illness or death with COVIDā19 increases with age, especially older adults who are at the highest risk [22]. This may be because SARSāCoVā2 spike proteins can weaken the DNA repair system of older people and consequently impede V(D)J recombination and adaptive immunity. In contrast, our data provide valuable details on the involvement of spike protein subunits in DNA damage repair, indicating that fullālength spikeābased vaccines may inhibit the recombination of V(D)J in B cells, which is also consistent with a recent study that a fullālength spikeābased vaccine induced lower antibody titers compared to the RBDābased vaccine [28]. This suggests that the use of antigenic epitopes of the spike as a SARSāCoVā2 vaccine might be safer and more efficacious than the fullālength spike. Taken together, we identified one of the potentially important mechanisms of SARSāCoVā2 suppression of the host adaptive immune machinery. Furthermore, our findings also imply a potential side effect of the fullālength spikeābased vaccine. This work will improve the understanding of COVIDā19 pathogenesis and provide new strategies for designing more efficient and safer vaccines.
Spike protein (inc vax) induced immunodeficiency & carcinogenesis megathread #2: SARSāCoVā2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
Spike protein (inc vax) induced immunodeficiency & carcinogenesis megathread #2: SARSāCoVā2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
Spike protein (inc vax) induced immunodeficiency & carcinogenesis megathread #2: SARSāCoVā2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro
Any extracts used in the following article are for non commercial research and educational purposes only and may be subject to copyright from their respective owners.
Share
SARSāCoVā2 Spike Impairs DNA Damage Repair and Inhibits V(D)J Recombination In Vitro (2021)
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) has led to the coronavirus disease 2019 (COVIDā19) pandemic, severely affecting public health and the global economy. Adaptive immunity plays a crucial role in fighting against SARSāCoVā2 infection and directly influences the clinical outcomes of patients. Clinical studies have indicated that patients with severe COVIDā19 exhibit delayed and weak adaptive immune responses; however, the mechanism by which SARSāCoVā2 impedes adaptive immunity remains unclear. Here, by using an in vitro cell line, we report that the SARSāCoVā2 spike protein significantly inhibits DNA damage repair, which is required for effective V(D)J recombination in adaptive immunity. Mechanistically, we found that the spike protein localizes in the nucleus and inhibits DNA damage repair by impeding key DNA repair protein BRCA1 and 53BP1 recruitment to the damage site. Our findings reveal a potential molecular mechanism by which the spike protein might impede adaptive immunity and underscore the potential side effects of full-length spike-based vaccines.
Keywords:Ā SARSāCoVā2;Ā spike;Ā DNA damage repair;Ā V(D)J recombination;Ā vaccine
1. Introduction
Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) is responsible for the ongoing coronavirus disease 2019 (COVIDā19) pandemic that has resulted in more than 2.3 million deaths. SARSāCoVā2 is an enveloped single positiveāsense RNA virus that consists of structural and nonāstructural proteins [1]. After infection, these viral proteins hijack and dysregulate the host cellular machinery to replicate, assemble, and spread progeny viruses [2]. Recent clinical studies have shown that SARSāCoVā2 infection extraordinarily affects lymphocyte number and function [3,4,5,6]. Compared with mild and moderate survivors, patients with severe COVIDā19 manifest a significantly lower number of total T cells, helper T cells, and suppressor T cells [3,4]. Additionally, COVIDā19 delays IgG and IgM levels after symptom onset [5,6]. Collectively, these clinical observations suggest that SARSāCoVā2 affects the adaptive immune system. However, the mechanism by which SARSāCoVā2 suppresses adaptive immunity remains unclear.
As two critical host surveillance systems, the immune and DNA repair systems are the primary systems that higher organisms rely on for defense against diverse threats and tissue homeostasis. Emerging evidence indicates that these two systems are interdependent, especially during lymphocyte development and maturation [7]. As one of the major double-strand DNA break (DSB) repair pathways, non-homologous end joining (NHEJ) repair plays a critical role in lymphocyteāspecific recombinationāactivating gene endonuclease (RAG) āmediated V(D)J recombination, which results in a highly diverse repertoire of antibodies in B cell and T cell receptors (TCRs) in T cells [8]. For example, loss of function of key DNA repair proteins such as ATM, DNAāPKcs, 53BP1, et al., leads to defects in the NHEJ repair which inhibit the production of functional B and T cells, leading to immunodeficiency [7,9,10,11]. In contrast, viral infection usually induces DNA damage via different mechanisms, such as inducing reactive oxygen species (ROS) production and host cell replication stress [12,13,14]. If DNA damage cannot be properly repaired, it will contribute to the amplification of viral infection-induced pathology. Therefore, we aimed to investigate whether SARSāCoVā2 proteins hijack the DNA damage repair system, thereby affecting adaptive immunity in vitro.
[2. Materials and Methods]
3. Results
3.1. Effect of NuclearāLocalized SARSāCoVā2 Viral Proteins on DNA Damage Repair
DNA damage repair occurs mainly in the nucleus to ensure genome stability. Although SARSāCoVā2 proteins are synthesized in the cytosol [1], some viral proteins are also detectable in the nucleus, including Nsp1, Nsp5, Nsp9, Nsp13, Nsp14, and Nsp16 [19]. We investigated whether these nuclear-localized SARSāCoVā2 proteins affect the host cell DNA damage repair system. For this, we constructed these viral protein expression plasmids together with spike and nucleoprotein expression plasmids, which are generally considered cytosolālocalized proteins. We confirmed their expression and localization by immunoblotting and immunofluorescence (Figure 1A andĀ Figure S1A). Our results were consistent with those from previous studies [19]; Nsp1, Nsp5, Nsp9, Nsp13, Nsp14, and Nsp16 proteins are indeed localized in the nucleus, and nucleoproteins are mainly localized in the cytosol. Surprisingly, we found the abundance of the spike protein in the nucleus (Figure 1A). NHEJ repair and homologous recombination (HR) repair are two major DNA repair pathways that not only continuously monitor and ensure genome integrity but are also vital for adaptive immune cell functions [9]. To evaluate whether these viral proteins impede the DSB repair pathway, we examined the repair of a site-specific DSB induced by the IāSceI endonuclease using the direct repeatāgreen fluorescence protein (DRāGFP) and the total-NHEJ-GFP (EJ5āGFP) reporter systems for HR and NHEJ, respectively [15,16]. Overexpression of Nsp1, Nsp5, Nsp13, Nsp14, and spike proteins diminished the efficiencies of both HR and NHEJ repair (Figure 1BāE andĀ Figure S2A,B). Moreover, we also found that Nsp1, Nsp5, Nsp13, and Nsp14 overexpression dramatically suppressed proliferation compared with other studied proteins (Figure S3A,B). Therefore, the inhibitory effect of Nsp1, Nsp5, Nsp13, and Nsp14 on DNA damage repair may be due to secondary effects, such as growth arrest and cell death. Interestingly, overexpressed spike protein did not affect cell morphology or proliferation but significantly suppressed both HR and NHEJ repair (Figure 1BāE,Ā Figures S2A,B and S3A,B).
Figure 1.Ā Effect of severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) nuclear-localized proteins on DNA damage repair. (A) Subcellular distribution of the SARSāCoVā2 proteins. Immunofluorescence was performed at 24 h after transfection of the plasmid expressing the viral proteins into HEK293T cells. Scale bar: 10 Āµm. (B) Schematic of the EJ5-GFP reporter used to monitor non-homologous end joining (NHEJ). (C) Effect of empty vector (E.V) and SARSāCoVā2 proteins on NHEJ DNA repair. The values represent the mean Ā± standard deviation (SD) from three independent experiments (see representative FACS plots inĀ Figure S2A). (D) Schematic of the DR-GFP reporter used to monitor homologous recombination (HR). (E) Effect of E.V and SARSāCoVā2 proteins on HR DNA repair. The values represent the mean Ā± SD from three independent experiments (see representative FACS plots inĀ Figure S2B). The values represent the mean Ā± SD,Ā nĀ = 3. Statistical significance was determined using one-way analysis of variance (ANOVA) in (C,E). **Ā pĀ < 0.01, ***Ā pĀ < 0.001, ****Ā pĀ < ā0.0001.
3.2. SARSāCoVā2 Spike Protein Inhibits DNA Damage Repair
Because spike proteins are critical for mediating viral entry into host cells and are the focus of most vaccine strategies [20,21], we further investigated the role of spike proteins in DNA damage repair and its associated V(D)J recombination. Spike proteins are usually thought to be synthesized on the rough endoplasmic reticulum (ER) [1]. After posttranslational modifications such as glycosylation, spike proteins traffic via the cellular membrane apparatus together with other viral proteins to form the mature virion [1]. Spike protein contains two major subunits, S1 and S2, as well as several functional domains or repeats [22] (Figure 2A). In the native state, spike proteins exist as inactive fullālength proteins. During viral infection, host cell proteases such as furin protease activate the S protein by cleaving it into S1 and S2 subunits, which is necessary for viral entry into the target cell [23]. We further explored different subunits of the spike protein to elucidate the functional features required for DNA repair inhibition. Only the fullālength spike protein strongly inhibited both NHEJ and HR repair (Figure 2BāE andĀ Figure S4A,B). Next, we sought to determine whether the spike protein directly contributes to genomic instability by inhibiting DSB repair. We monitored the levels of DSBs using comet assays. Following different DNA damage treatments, such as Ī³āirradiation, doxorubicin treatment, and H2O2Ā treatment, there is less repair in the presence of the spike protein (Figure 2F,G). Together, these data demonstrate that the spike protein directly affects DNA repair in the nucleus.
Figure 2.Ā Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) spike protein inhibits DNA damage repair. (A) Schematic of the primary structure of the SARSāCoVā2 spike protein. The S1 subunit includes an Nāterminal domain (NTD, 14ā305 residues) and a receptorābinding domain (RBD, 319ā541 residues). The S2 subunit consists of the fusion peptide (FP, 788ā806 residues), heptapeptide repeat sequence 1 (HR1, 912ā984 residues), HR2 (1163ā1213 residues), TM domain (TM, 1213ā1237 residues), and cytoplasm domain (CT,1237ā1273 residues). (B,C) Effect of titrated expression of the spike protein on DNA repair in HEKā293T cells. (D,E) Only full-length spike protein inhibits non-homologous end joining (NHEJ) and homologous recombination (HR) DNA repair. The values represent the mean Ā± SD from three independent experiments (see representative FACS plots inĀ Figure S4A,B). (F) Fullālength spike (SāFL) proteinātransfected HEK293T cells exhibited more DNA damage than empty vector-, S1ā, and S2ātransfected cells under different DNA damage conditions. For doxorubicin: 4 Āµg/mL, 2 h. For Ī³āirradiation: 10 Gy, 30 min. For H2O2: 100 ĀµM, 1 h. Scale bar: 50 Āµm. (G) Corresponding quantification of the comet tail moments from 20 different fields withĀ nĀ > 200 comets of three independent experiments. Statistical significance was assessed using a two-way analysis of variance (ANOVA). NS (Not Significant): *Ā pĀ > 0.05, **Ā pĀ <ā0.01, ***Ā pĀ < 0.001, ****Ā pĀ < 0.0001.
3.3. Spike Proteins Impede the Recruitment of DNA Damage Repair Checkpoint Proteins
To confirm the existence of spike protein in the nucleus, we performed subcellular fraction analysis and found that spike proteins are not only enriched in the cellular membrane fraction but are also abundant in the nuclear fraction, with detectable expression even in the chromatinābound fraction (Figure 3A). We also observed that the spike has three different forms, the higher band is a highly glycosylated spike, the middle one is a fullālength spike, and the lower one is a cleaved spike subunit. Consistent with the comet assay, we also found the upregulation of the DNA damage marker, Ī³āH2A.X, in spike proteināoverexpressed cells under DNA damage conditions (Figure 3B). A recent study suggested that spike proteins induce ER stress and ERāassociated protein degradation [24]. To exclude the possibility that the spike protein inhibits DNA repair by promoting DNA repair protein degradation, we checked the expression of some essential DNA repair proteins in NHEJ and HR repair pathways and found that these DNA repair proteins were stable after spike protein overexpression (Figure 3C). To determine how the spike protein inhibits both NHEJ and HR repair pathways, we analyzed the recruitment of BRCA1 and 53BP1, which are the key checkpoint proteins for HR and NHEJ repair, respectively. We found that the spike protein markedly inhibited both BRCA1 and 53BP1 foci formation (Figure 3DāG). Together, these data show that the SARSāCoVā2 fullālength spike protein inhibits DNA damage repair by hindering DNA repair protein recruitment.
Figure 3.Ā Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) spike protein impedes the recruitment of DNA damage repair checkpoint proteins. (A) Membrane fraction (MF), cytosolic fraction (CF), soluble nuclear fraction (SNF), and chromatin-bound fraction (CBF) from HEK293T cells transfected with SARSāCoVā2 spike protein were immunoblotted for His-tag spike and indicated proteins. (B) Left: Immunoblots of DNA damage marker Ī³H2AX in empty vector (E.V)ā and spike proteināexpressing HEK293T cells after 10 Gy Ī³-irradiation. Right: corresponding quantification of immunoblots in left. The values represent the mean Ā± SD (nĀ = 3). Statistical significance was determined using StudentāsĀ t-test. ****Ā pā< 0.0001. (C) Immunoblots of DNA damage repair related proteins in spike proteināexpressing HEK293T cells. (D) Representative images of 53BP1 foci formation in E.Vā and spike protein-expressing HEK293 cells exposed to 10 Gy Ī³āirradiation. Scale bar: 10 Āµm. (E) Quantitative analysis of 53BP1 foci per nucleus. The values represent the mean Ā± SEM,Ā nĀ = 50. (F) BRCA1 foci formation in empty vector- and spike protein-expressing HEK293 cells exposed to 10 Gy Ī³āirradiation. Scale bar: 10 Āµm. (G). Quantitative analysis of BRCA1 foci per nucleus. The values represent the mean Ā± SEM,Ā nĀ = 50. Statistical significance was determined using StudentāsĀ t-test. ****Ā pĀ < 0.0001.
3.4. Spike Protein Impairs V(D)J Recombination In vitro
DNA damage repair, especially NHEJ repair, is essential for V(D)J recombination, which lies at the core of B and T cell immunity [9]. To date, many approved SARSāCoVā2 vaccines, such as mRNA vaccines and adenovirusāCOVIDā19 vaccines, have been developed based on the fullālength spike protein [25]. Although it is debatable whether SARSāCoVā2 directly infects lymphocyte precursors [26,27], some reports have shown that infected cells secrete exosomes that can deliver SARSāCoVā2 RNA or protein to target cells [28,29]. We further tested whether the spike protein reduced NHEJāmediated V(D)J recombination. For this, we designed an in vitro V(D)J recombination reporter system according to a previous study [18] (Figure S5). Compared with the empty vector, spike protein overexpression inhibited RAGāmediated V(D)J recombination in this in vitro reporter system (Figure 4).
Figure 4.Ā Spike protein impairs V(D)J recombination in vitro. (A) Schematic of the V(D)J reporter system. (B) Representative plots of flow cytometry show that the SARSāCoVā2 spike protein impedes V(D)J recombination in vitro. (C) Quantitative analysis of relative V(D)J recombination. The values represent the mean Ā± SD,Ā nĀ = 3. Statistical significance was determined using StudentāsĀ t-test. ****Ā pĀ < 0.0001.
4. Discussion
Our findings provide evidence of the spike protein hijacking the DNA damage repair machinery and adaptive immune machinery in vitro. We propose a potential mechanism by which spike proteins may impair adaptive immunity by inhibiting DNA damage repair. Although no evidence has been published that SARSāCoVā2 can infect thymocytes or bone marrow lymphoid cells, our in vitro V(D)J reporter assay shows that the spike protein intensely impeded V(D)J recombination. Consistent with our results, clinical observations also show that the risk of severe illness or death with COVIDā19 increases with age, especially older adults who are at the highest risk [22]. This may be because SARSāCoVā2 spike proteins can weaken the DNA repair system of older people and consequently impede V(D)J recombination and adaptive immunity. In contrast, our data provide valuable details on the involvement of spike protein subunits in DNA damage repair, indicating that fullālength spikeābased vaccines may inhibit the recombination of V(D)J in B cells, which is also consistent with a recent study that a fullālength spikeābased vaccine induced lower antibody titers compared to the RBDābased vaccine [28]. This suggests that the use of antigenic epitopes of the spike as a SARSāCoVā2 vaccine might be safer and more efficacious than the fullālength spike. Taken together, we identified one of the potentially important mechanisms of SARSāCoVā2 suppression of the host adaptive immune machinery. Furthermore, our findings also imply a potential side effect of the fullālength spikeābased vaccine. This work will improve the understanding of COVIDā19 pathogenesis and provide new strategies for designing more efficient and safer vaccines.
Full paper:
https://www.mdpi.com/1999-4915/13/10/2056
Share
Buy me a coffeeā